An observational study in Propofol, sponsored by Shanghai Zhongshan Hospital. Status unknown. Open to male participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2018-12-03.
Sponsored by Shanghai Zhongshan Hospital · Observational
The aim of this study is to determine whether ALDH2 gene polymorphisms (G/G, G/A A/A) have effect on the potency of propofol.
89 studies on the registry are indexed under Unconsciousness; 11 are open to participants now.
This study's planned enrollment of 100 is above the median of 80 across 30 observational studies indexed under Unconsciousness.
Browse Unconsciousness studies →Shanghai Zhongshan Hospital is the lead sponsor of 636 studies on the registry; 283 are open to participants now.
Counted across the registry records on this site, refreshed daily.
operation rooms for cardiac surgeries in our institution（a major hospital in China)
Exclusion Criteria:
Patients who are determined to be G/G genotype.
Drug: Propofol
Patients who are determined to be G/A or A/A genotypes.
Drug: Propofol
Patients will be induced to unconsciousness using propofol intravenously.
Effect-site concentration
patient's effect-site concentration when he/she loss consciousness
Time frame: immediately after patient lose his/her consciousness
No study locations are listed for this record.
This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Zhongshan Hospital